Stylus Medicine (Series A extension)

Funding Details
Awarder
Inbox
Date Award
May 13, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Stylus Medicine is a biotechnology company dedicated to developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics.
Market
Genetic Medicines
Location
Cambridge, MA, USA
Coinvestors
RA Capital Management, Khosla Ventures, Chugai Venture Fund, Eli Lilly and Company, Johnson & Johnson Innovation - JJDC

Links
Back to Home Back to Biotechnology Deals View Funding Announcement